Consistent time-varying association between ctDNA and post-resection colon and rectal cancer recurrence: The β-CORRECT study
In this retrospective study of 468 patients with Stage II, III, or resectable Stage IV colorectal cancer (CRC), the association between circulating tumor DNA (ctDNA) detected with a tumor-informed molecular residual disease (MRD) assay and recurrence was evaluated. Tumor DNA and RNA sequencing of tumors were also performed to assess associations of tumor genomic alterations and expression with ctDNA status, DFS, and site of recurrence. Among 417 patients with a median follow-up of 1.9 years, ctDNA detection was strongly associated with shorter DFS during surveillance (HR 36.6), post-surgery (HR 7.5) and post-definitive therapy (HR 24.0), independent of clinicopathological factors. Each 10-fold increase in ctDNA level was associated with a two-fold increase in recurrence risk. Median lead time between ctDNA detection and clinical recurrence was 97 days. Among ctDNA-positive patients, adjuvant chemotherapy was associated with improved DFS (HR = 0.3), whereas no benefit was observed among ctDNA-negative patients (HR = 1.8). Significant interactions were observed between ctDNA status and RAS/BRAF alterations and WNT and MAPK pathway alterations. RNA sequencing identified distinct expression patterns associated with the epithelial-mesenchymal transition. These findings support ctDNA as an independent prognostic marker in resected CRC and identify molecular features associated with MRD and recurrence risk.
Authors
- Yusuke Suwa (ORCID: https://orcid.org/0000-0002-3738-9393)
- 乞宗泰
- Judith Frederick
- Amin R. Mazloom (ORCID: https://orcid.org/0000-0001-6654-819X)
- Jenny You
- Janine R. Lobello (ORCID: https://orcid.org/0009-0008-9704-0514)
- Nishitha Therala
- Hiroya Taniguchi (ORCID: https://orcid.org/0000-0003-1407-6682)
- Naoya Akazawa (ORCID: https://orcid.org/0000-0002-2891-6550)
- Ichiro Takemasa (ORCID: https://orcid.org/0000-0003-1595-2453)
- Melanie R. Palomares (ORCID: https://orcid.org/0000-0003-4356-1724)
- Rizi Ai (ORCID: https://orcid.org/0000-0002-1605-7533)
- Paige Innis
- Daisuke Kotani (ORCID: https://orcid.org/0000-0002-4196-555X)
- Kozo Kataoka (ORCID: https://orcid.org/0000-0003-2043-8184)
- Martin You (ORCID: https://orcid.org/0009-0006-2729-8582)
- Kentaro Yamazaki (ORCID: https://orcid.org/0000-0001-6269-9345)
- Hideaki Bando (ORCID: https://orcid.org/0000-0001-5041-2765)
- Jorge Garces (ORCID: https://orcid.org/0009-0008-2905-1967)
- David W. Hall (ORCID: https://orcid.org/0000-0001-7708-6656)
- Gregory S. Young (ORCID: https://orcid.org/0000-0001-9886-6205)
- Tara Marti (ORCID: https://orcid.org/0000-0002-6362-5775)
- Masahito Kotaka (ORCID: https://orcid.org/0000-0001-5976-613X)
- Saori Mishima (ORCID: https://orcid.org/0000-0002-5922-1487)
- Eiji Oki (ORCID: https://orcid.org/0000-0002-9763-9366)
- Aimee J. Foreman
- Keiji Hirata (ORCID: https://orcid.org/0000-0001-6461-5109)
- Darl D. Flake (ORCID: https://orcid.org/0000-0003-4699-0938)
- Sarah Abdul‐Wajid (ORCID: https://orcid.org/0000-0002-6000-7226)
- Frederick L. Baehner (ORCID: https://orcid.org/0000-0001-6883-1212)
- Daniel Cuevas
- Hiromichi Ebi (ORCID: https://orcid.org/0000-0003-3155-7576)
- Gloria Chan Johnson
- Satish Seerapu
- Somasundaram Subramaniam
- S. Lockton
- Gargi Dan Basu (ORCID: https://orcid.org/0000-0003-0352-5972)
- Gina L. Costa (ORCID: https://orcid.org/0000-0002-9626-8620)
- Matthew Wallace
- Greg Grasse
- Garrett Brady
- John Hu
- 忠美 橋本
- Cole Richwine
- Michal Wojcik
- Mohammad Abbasi
- Nila Balendra
- Clem Uwimana
- Nikolas Delgado
- Frankie Garcia-Patrick
- Bingbing Song
- Mayumi Smyers
- Flavio Beas
- Benjamin Camptell
- Yoshiaki Nakamura
- Emad Samani
- Exact Sciences MRD Group
- Jun Watanabe
- Gabriel Fung
- Naoki Nariai
- Andrea Johnson
- Hannah Mooney
- Scott Hunicke-Smith
- Suzanne Melanson
- Jessica Talamante
- Takayuki Yoshino
- Takeshi Kato
- Joseph Rose
Institutions
- Kansai Medical University (JP)
- Kyushu University (JP)
- Hyogo Medical University (JP)
- University of Occupational and Environmental Health Japan (JP)
- Yokohama City University Medical Center (JP)
- University of Oxford (GB)
- National Cancer Centre Japan (JP)
- Shizuoka Cancer Center (JP)
- Osaka National Hospital (JP)
- Exact Sciences (United States) (US)
- Osaka Police Hospital (JP)
- Sendai Medical Center (JP)
- Aichi Cancer Center (JP)
- National Cancer Center Hospital East (JP)
- Sano Hospital (JP)
- Sendai City Medical Center (JP)
- Sendai Open Hospital (JP)
- Aichi Cancer Center Research Institute (JP)
- Aichi Cancer Center Hospital (JP)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-79295-3
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development